As we filed the IND by 6/30/11 and the FDA having 30 days to either approve or place it on clinical hold, it appears that 113 should be approved for Phase 1 sometime late this month, with a launch sometime of next month.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.